Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery—a Post Hoc Analysis of the FibroTest Prospective Study-Reference-Cited by-同舟云学术

Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery—a Post Hoc Analysis of the FibroTest Prospective Study

Published:2021-04-12 Issue: Volume: Page:
ISSN:0960-8923
Container-title:Obesity Surgery
language:en
Short-container-title:OBES SURG

Author:

Codjia Tatiana^ORCID,Rebibo Lionel,François Arnaud,Lagnel Carole,Huet Emmanuel,Bekri Soumeya,Pattou François,Régimbeau Jean-Marc,Schwarz Lilian

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s11695-021-05402-0.pdf

Reference38 articles.

1. Eckel RH, Alberti K, Grundy SM, et al. The metabolic syndrome. Lancet. 2010;375(9710):181–3.

2. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113–21.

3. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–402.

4. Brunt EM, Wong VW-S, Nobili V, et al. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015;1:15080.

5. Taitano AA, Markow M, Finan JE, et al. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg. 2015;19(3):429–37.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stage of fibrosis is not a predictive determinant of weight loss in patients undergoing bariatric surgery;Surgery for Obesity and Related Diseases;2024-08

2. Current and Potential Applications of Artificial Intelligence in Metabolic Bariatric Surgery;Bariatric Surgery - Past and Present;2023-02-15

3. Bariatric Surgery and Metabolic Dysfunction-Associated Fatty Liver Disease: a 2022 Update;Praxis;2023-02

4. Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments?;Frontiers in Endocrinology;2022-11-29